View as an RSS Feed
View Science-Of-Aging's Articles BY TICKER:
Osiris Therapeutics: Poised For Another Breakout
- Osiris recently became profitable with impressive sales growth yet the market failed to react to this news.
- Osiris's mature stem cell products have shown overwhelming efficacy and they have plenty of funds to market them.
- Osiris presents tremendous value to the investor as the market has failed to account for sales growth and reduced R&D costs.
- Osiris Therapeutics: Still The Best Bet In Regenerative Medicine
- Osiris Therapeutics: An Old Stem Cell Biotech Coming Of Age